Regenxbio Stock Market Value
| RGNX Stock | USD 9.58 0.01 0.10% |
| Symbol | Regenxbio |
Regenxbio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Regenxbio. If investors know Regenxbio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Regenxbio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (5.01) | Revenue Per Share 1.765 | Quarterly Revenue Growth (0.16) | Return On Assets (0.26) | Return On Equity (0.72) |
The market value of Regenxbio is measured differently than its book value, which is the value of Regenxbio that is recorded on the company's balance sheet. Investors also form their own opinion of Regenxbio's value that differs from its market value or its book value, called intrinsic value, which is Regenxbio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Regenxbio's market value can be influenced by many factors that don't directly affect Regenxbio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Regenxbio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Regenxbio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Regenxbio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Regenxbio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Regenxbio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Regenxbio.
| 10/27/2024 |
| 11/26/2024 |
If you would invest 0.00 in Regenxbio on October 27, 2024 and sell it all today you would earn a total of 0.00 from holding Regenxbio or generate 0.0% return on investment in Regenxbio over 30 days. Regenxbio is related to or competes with Day One, Replimune, Mirum Pharmaceuticals, Rocket Pharmaceuticals, Avidity Biosciences, Uniqure NV, and Protagonist Therapeutics. REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cel... More
Regenxbio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Regenxbio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Regenxbio upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 32.22 | |||
| Value At Risk | (7.20) | |||
| Potential Upside | 5.72 |
Regenxbio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Regenxbio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Regenxbio's standard deviation. In reality, there are many statistical measures that can use Regenxbio historical prices to predict the future Regenxbio's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.48) | |||
| Total Risk Alpha | (0.94) | |||
| Treynor Ratio | (0.09) |
Regenxbio Backtested Returns
Regenxbio maintains Sharpe Ratio (i.e., Efficiency) of -0.0457, which implies the firm had a -0.0457% return per unit of risk over the last 3 months. Regenxbio exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Regenxbio's Coefficient Of Variation of (2,471), risk adjusted performance of (0.02), and Variance of 21.84 to confirm the risk estimate we provide. The company holds a Beta of 2.31, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Regenxbio will likely underperform. At this point, Regenxbio has a negative expected return of -0.22%. Please make sure to check Regenxbio's standard deviation, potential upside, as well as the relationship between the Potential Upside and day median price , to decide if Regenxbio performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.53 |
Good reverse predictability
Regenxbio has good reverse predictability. Overlapping area represents the amount of predictability between Regenxbio time series from 27th of October 2024 to 11th of November 2024 and 11th of November 2024 to 26th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Regenxbio price movement. The serial correlation of -0.53 indicates that about 53.0% of current Regenxbio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.53 | |
| Spearman Rank Test | -0.75 | |
| Residual Average | 0.0 | |
| Price Variance | 0.53 |
Regenxbio lagged returns against current returns
Autocorrelation, which is Regenxbio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Regenxbio's stock expected returns. We can calculate the autocorrelation of Regenxbio returns to help us make a trade decision. For example, suppose you find that Regenxbio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Regenxbio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Regenxbio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Regenxbio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Regenxbio stock over time.
Current vs Lagged Prices |
| Timeline |
Regenxbio Lagged Returns
When evaluating Regenxbio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Regenxbio stock have on its future price. Regenxbio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Regenxbio autocorrelation shows the relationship between Regenxbio stock current value and its past values and can show if there is a momentum factor associated with investing in Regenxbio.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Regenxbio Stock Analysis
When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.